Home
Storia in 3 fonti
Pfizer Lyme Disease Vaccine Shows 70% Efficacy, But Misses Statistical Goal
The vaccine demonstrated a reduction in the rate of infections, but fell short of a key statistical requirement.
- ·
cnbc.com
Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss
Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle weakness and pain.
- ·
huffpost.com
Pfizer Lyme Disease Vaccine Shows 70% Efficacy, But Misses Statistical Goal
The vaccine demonstrated a reduction in the rate of infections, but fell short of a key statistical requirement.
- ·
usatoday.com
Lyme disease vaccine shows strong results. How it works.
The first human Lyme disease vaccine was 73% effective against the tick-borne illness, says Pfizer. They still plan to seek approval.